X

Vous n'êtes pas connecté

  - ONCOLOGYNEWS.COM.AU - A La Une - 23/Jun 19:30

Clues behind drug resistance in bowel cancer

Cancer Research UK-funded scientists at The Institute of Cancer Research, London, UK, have discovered what may cause some treatments to stop working in people living with bowel cancer, a type of cancer which causes around 16,800 deaths in the UK every year. The findings could help researchers use information about a person’s cancer to make [...]

Articles similaires

Clues behind drug resistance in bowel cancer

oncologynews.com.au - 23/Jun 19:30

Cancer Research UK-funded scientists at The Institute of Cancer Research, London, UK, have discovered what may cause some treatments to stop working...

Scorpion venom offers new hope for breast cancer patients: Study

times of india - 12:18

Brazilian scientists have identified a molecule, BamazScplp1, in Amazonian scorpion venom that effectively kills breast cancer cells in early tests....

Sorry! Image not available at this time

Engineers Turn Toxic Fungus Found in Ancient Tomb into Anti-Cancer Drug

greekreporter.com - 08:11

Researchers at the University of Pennsylvania have transformed a toxic fungus once linked to deaths in ancient tombs into an anti-cancer drug. The...

Sorry! Image not available at this time

New Study Links ChatGPT to Decline in Critical Thinking

greekreporter.com - 20:34

A new study from the Massachusetts Institute of Technology (MIT) suggests that regular use of AI writing tools, like ChatGPT, may reduce a person’s...

📻 Day In Loo 2025 - The Radio Show

hauraki.co.nz - 18/Jun 10:50

We’re live from the ‘Bowels of Eden Park’ for the annual Radio Hauraki Day in Loo with Bowel Cancer NZ. We’re doing this...

📻 Day In Loo 2025 - The Radio Show

hauraki.co.nz - 18/Jun 10:50

We’re live from the ‘Bowels of Eden Park’ for the annual Radio Hauraki Day in Loo with Bowel Cancer NZ. We’re doing this...

Thousands of blood cancer patients could benefit from new drug combination

oncologynews.com.au - 23/Jun 19:26

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay...

Thousands of blood cancer patients could benefit from new drug combination

oncologynews.com.au - 23/Jun 19:26

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay...

This drug may lower dementia risk in people with type 2 diabetes, study finds

knowridge.com - 10:39

A large study led by researchers at Case Western Reserve University suggests that semaglutide—a drug already popular for managing type 2 diabetes...

This drug may lower dementia risk in people with type 2 diabetes, study finds

knowridge.com - 10:39

A large study led by researchers at Case Western Reserve University suggests that semaglutide—a drug already popular for managing type 2 diabetes...

Les derniers communiqués

  • Aucun élément